Citadel Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-14,600
| Closed | -$127K | – | 15318 |
|
|
2021
Q3 | $127K | Sell |
14,600
-7,300
| -33% | -$66.6K | ﹤0.01% | 12582 |
|
|
2021
Q2 | $224K | Sell |
21,900
-5,900
| -21% | -$62.3K | ﹤0.01% | 11921 |
|
|
2021
Q1 | $332K | Sell |
27,800
-9,900
| -26% | -$112K | ﹤0.01% | 10606 |
|
|
2020
Q4 | $343K | Buy |
37,700
+20,600
| +120% | +$159K | ﹤0.01% | 8840 |
|
|
2020
Q3 | $104K | Buy |
17,100
+2,000
| +13% | +$15.3K | ﹤0.01% | 9256 |
|
|
2020
Q2 | $134K | Buy |
+15,100
| New | +$130K | ﹤0.01% | 8819 |
|
|
2020
Q1 | – | Sell |
-32,700
| Closed | -$288K | – | 10428 |
|
|
2019
Q4 | $288K | Buy |
+32,700
| New | +$245K | ﹤0.01% | 7645 |
|
|
2019
Q3 | – | Sell |
-25,100
| Closed | -$105K | – | 9976 |
|
|
2019
Q2 | $105K | Sell |
25,100
-77,300
| -75% | -$408K | ﹤0.01% | 8518 |
|
|
2019
Q1 | $644K | Buy |
102,400
+82,700
| +420% | +$579K | ﹤0.01% | 6364 |
|
|
2018
Q4 | $128K | Sell |
19,700
-14,500
| -42% | -$111K | ﹤0.01% | 8139 |
|
|
2018
Q3 | $284K | Buy |
+34,200
| New | +$260K | ﹤0.01% | 7659 |
|
|
2018
Q1 | – | Sell |
-10,800
| Closed | -$71K | – | 8981 |
|
|
2017
Q4 | $71K | Sell |
10,800
-3,200
| -23% | -$19.5K | ﹤0.01% | 7535 |
|
|
2017
Q3 | $78K | Sell |
14,000
-500
| -3% | -$3.37K | ﹤0.01% | 7101 |
|
|
2017
Q2 | $112K | Sell |
14,500
-2,900
| -17% | -$24.5K | ﹤0.01% | 6867 |
|
|
2017
Q1 | $157K | Buy |
17,400
+1,800
| +12% | +$18.8K | ﹤0.01% | 6665 |
|
|
2016
Q4 | $169K | Sell |
15,600
-2,400
| -13% | -$32K | ﹤0.01% | 6424 |
|
|
2016
Q3 | $294K | Buy |
+18,000
| New | +$253K | ﹤0.01% | 5702 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$54K | – | 8356 |
|
|
2015
Q4 | $54K | Buy |
5,000
+500
| +11% | +$4.52K | ﹤0.01% | 7252 |
|
|
2015
Q3 | $31K | Buy |
4,500
+2,300
| +105% | +$17.8K | ﹤0.01% | 7902 |
|
|
2015
Q2 | $20K | Buy |
+2,200
| New | +$16.7K | ﹤0.01% | 8156 |
|
Other funds holding NPTN
Citadel Advisors's NPTN Position: Q3 2022 in Review
Citadel Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 260,595 shares — an estimated $4.1M sold.
Citadel Advisors first reported a position in NPTN in Q2 2014 and held it in 29 quarters. The position peaked at $6.88M in Q1 2016. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Citadel Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Citadel Advisors sold 260,595 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.1M.
- Citadel Advisors first reported a position in NEOPHOTONICS CORP in Q2 2014 and held it in 29 quarters.
- Citadel Advisors's NEOPHOTONICS CORP position peaked at $6.88M in Q1 2016.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.